Immune-mediated cardiovascular adverse events associated with oncological immunotherapies: an integrative review

Key Result

Oncological immunotherapies are associated with immune-mediated cardiovascular adverse events.

Key Points

• This review aims to summarize and evaluate the cardiovascular adverse events associated with oncological immunotherapies.
• Integrative review of existing literature on immunotherapy and its immune-mediated cardiovascular effects.
• Analysis of published cases and clinical outcomes related to adverse cardiovascular events.
• Examination of mechanisms through which immunotherapies induce cardiovascular issues.
• Identification of various immune-mediated cardiovascular events such as myocarditis and pericarditis.
• Increased prevalence of cardiovascular complications in patients receiving specific immunotherapies.
• Highlighting the need for monitoring cardiovascular health in oncology patients undergoing immunotherapy.